Liu Yang, Chen Shuchun, Zhang Dongmei, Li Zelin, Wang Xing, Xie Xing, Zhu Haijiao, Ren Luping, Wang Liqin
Department of Endocrinology, Hebei General Hospital.
Department of Endocrinology.
Medicine (Baltimore). 2020 May 29;99(22):e20437. doi: 10.1097/MD.0000000000020437.
To study the changes of pancreas, thyroid, adrenal, parathyroid and gonadal organ-specific antibodies in patients with type 1 diabetic patients and to explore the risk of development to other endocrine gland autoimmune diseases.Fifty one patients with type 1 diabetes mellitus were selected. ELISA was used to detect islet, adrenal gland, Parathyroid, gonadal organ-specific antibody levels, the level of thyroid-related antibodies by lectrochemiluminescence.Compared with the healthy control group, the levels of the 17-α-OHAb, 21-OHAb, NALP5Ab, P450sccAb, and CaSRAb in the T1DM group were significantly higher. GADAb-positive patients were more likely to have TPOAb-positive patients than GADAb-negative patients, and the positive rate of 2 thyroid antibodies in GADAb-positive patients was significantly higher than that in GADAb-negative patients. The presence of these antibodies is related to the age of onset of type 1 diabetes or Patient age. In combination with 1 or 2 islet antibody-positive patients, the combined non-islet antibody positive rate was higher than that of islet antibody-negative patients.Patients with type 1 diabetes with other autoimmune diseases at risk significantly increased compared with normal, of which the most common thyroid autoimmune disease, thyroid antibodies and hormone levels should be routinely detected at the first visit and long-term follow-up.
研究1型糖尿病患者胰腺、甲状腺、肾上腺、甲状旁腺及性腺器官特异性抗体的变化,探讨其发生其他内分泌腺自身免疫性疾病的风险。选取51例1型糖尿病患者。采用酶联免疫吸附测定(ELISA)检测胰岛、肾上腺、甲状旁腺、性腺器官特异性抗体水平,采用电化学发光法检测甲状腺相关抗体水平。与健康对照组相比,1型糖尿病组17-α-羟化酶抗体(17-α-OHAb)、21-羟化酶抗体(21-OHAb)、NALP5抗体(NALP5Ab)、细胞色素P450侧链裂解酶抗体(P450sccAb)及钙敏感受体抗体(CaSRAb)水平显著升高。谷氨酸脱羧酶抗体(GADAb)阳性患者比GADAb阴性患者更易出现甲状腺过氧化物酶抗体(TPOAb)阳性,且GADAb阳性患者中2种甲状腺抗体的阳性率显著高于GADAb阴性患者。这些抗体的存在与1型糖尿病的发病年龄或患者年龄有关。合并1种或2种胰岛抗体阳性的患者,非胰岛抗体合并阳性率高于胰岛抗体阴性患者。1型糖尿病患者发生其他自身免疫性疾病的风险较正常人显著增加,其中最常见的是甲状腺自身免疫性疾病,初诊及长期随访时均应常规检测甲状腺抗体及激素水平。